Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats
暂无分享,去创建一个
Yuji Wada | Y. Wada | Y. Koshino | Yoshifumi Koshino | J. Shiraishi | Mitsuhiko Nakamura | Jun Shiraishi | Mitsuhiko Nakamura
[1] C. de Montigny,et al. Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain , 1987, Synapse.
[2] R. Glennon,et al. Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice. , 1990, European journal of pharmacology.
[3] C. Sotelo,et al. Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei , 1990, The European journal of neuroscience.
[4] R. Nicoll,et al. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. , 1987, The Journal of physiology.
[5] D. Middlemiss,et al. Centrally active 5-HT receptor agonists and antagonists , 1992, Neuroscience & Biobehavioral Reviews.
[6] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[7] J W Dailey,et al. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. , 1994, European journal of pharmacology.
[8] Y. Wada,et al. Suppressive effects ofl-5-hydroxytryptophan in a feline model of photosensitive epilepsy , 1991, Brain Research.
[9] D. Mckenna. Chronic treatment with (W)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain , 1989 .
[10] R. North,et al. 5‐Hydroxytryptamine acts at 5‐HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones. , 1989, The Journal of physiology.
[11] J. Fozard,et al. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. , 1984, European journal of pharmacology.
[12] DH Bobker. A slow excitatory postsynaptic potential mediated by 5-HT2 receptors in nucleus prepositus hypoglossi , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] R. Andrade,et al. 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex , 1991, Neuroscience.
[14] R. Racine,et al. Kindling: basic mechanisms and clinical validity. , 1990, Electroencephalography and clinical neurophysiology.
[15] Y. Wada,et al. Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy , 1992, Neuroscience Letters.
[16] K. Alkadhi,et al. Inhibition of epileptiform activity by serotonin in rat CA1 neurons , 1995, Brain Research.
[17] Nariyoshi Yamaguchi,et al. Role of serotonin receptor subtype in seizures kindled from the feline hippocampus , 1992, Neuroscience Letters.
[18] Nariyoshi Yamaguchi,et al. Intra-hippocampal injection of 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats , 1993, Neuroscience Letters.
[19] D. Taylor,et al. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat , 1983, Neuropharmacology.
[20] R. Racine,et al. Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.
[21] M. Pranzatelli. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI) , 1990, Neuroscience Letters.
[22] A. Colino,et al. Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin , 1987, Nature.
[23] M. E. Corcoran,et al. Frontal Lobe and Kindling in the Rat , 1975, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[24] R. Glennon,et al. Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin. , 1992, The Journal of pharmacology and experimental therapeutics.